ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 76,322 | 55,970 | 30,082 | 20,371 | 435 |
| Cost of Goods | 12,692 | 11,473 | 9,974 | 9,167 | N/A |
| Gross Profit | 63,630 | 44,497 | 20,108 | 11,204 | 435 |
| Operating Expenses | 31,622 | 24,964 | 20,184 | 11,413 | 51,362 |
| Operating Income | 32,700 | 20,006 | 898 | -42 | -50,927 |
| Interest Expense | 11,008 | 787 | 467 | 1,327 | 682 |
| Other Income | 41 | 160 | -305 | -241 | 0 |
| Pre-tax Income | 21,733 | 19,379 | 126 | -1,610 | -51,609 |
| Income Tax | 6,358 | -9,368 | 20 | -36 | 0 |
| Net Income Continuous | 15,375 | 28,747 | 106 | -1,574 | -51,609 |
| Net Income Discontinuous | N/A | N/A | 195 | 68 | N/A |
| Net Income | $15,375 | $28,747 | $301 | $-1,506 | $-51,609 |
| EPS Basic Total Ops | 1.34 | 2.61 | -0.92 | N/A | -18.90 |
| EPS Basic Continuous Ops | 1.35 | 2.63 | -0.96 | N/A | -18.88 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.04 | N/A | N/A |
| EPS Diluted Total Ops | 1.32 | 2.59 | -0.92 | N/A | -18.90 |
| EPS Diluted Continuous Ops | 1.33 | 2.60 | -0.96 | N/A | -18.88 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.04 | N/A | N/A |
| EBITDA(a) | $39,600 | $23,884 | $2,008 | $525 | $-50,779 |